KMID : 1188320210150010100
|
|
Gut and Liver 2021 Volume.15 No. 1 p.100 ~ p.108
|
|
Astragalin Inhibits Nuclear Factor-¥êB Signaling in Human Colonic Epithelial Cells and Attenuates Experimental Colitis in Mice
|
|
Han Yoo-Min
Koh Jae-Moon Kim Jee-Hyun Lee Joo-Young Im Jong-Pil Kim Joo-Sung
|
|
Abstract
|
|
|
Background/Aims: Astragalin (kaempferol-3-O-¥â-D-glucoside) is a flavonoid isolated from the leaves of persimmon or Rosa agrestis. Astragalin exhibits various anti-inflammatory properties; however, little is known about its therapeutic potential for inflammatory bowel disease (IBD). This study aims to investigate the anti-inflammatory effect of astragalin via blockade of the nuclear factor ¥êB (NF-¥êB) signaling pathway in human colonic epithelial cells and a murine colitis model.
Methods: HCT-116 and HT-29 human colonic epithelial cells were pretreated with astragalin and stimulated with tumor necrosis factor-¥á (TNF-¥á). Cell viability was assessed by the MTS assay. Real-time reverse transcription polymerase chain reaction was used to analyze the messenger RNA expression of the inflammatory cytokines interleukin (IL)-6 and IL-8. The effect of astragalin on the NF-¥êB pathway was evaluated by Western blot analysis of inhibitor of NF-¥êB alpha (I¥êB¥á) phosphorylation/degradation and by electrophoretic mobility shift assay. Dextran sulfate sodium (DSS)-induced acute murine colitis model was used for in vivo experiments.
Results: Astragalin strongly suppressed the expression of proinflammatory cytokines in human colonic epithelial cells in a dose-dependent manner. Western blot analysis showed that astragalin inhibited I¥êB¥á phosphorylation/degradation. Additionally, astragalin reduced the DNA binding activity of NF-¥êB. Astragalin alleviated colon shortening and improved the pathologic scores in DSS-induced acute murine colitis model. Furthermore, astragalin reduced the level of phosphorylated I¥êB¥á and decreased the production of the inflammatory cytokines IL-6, IL-8, and TNF-¥á in the DSS-treated colon mucosa.
Conclusions: Astragalin exerted an anti-inflammatory effect through NF-¥êB pathway inhibition and attenuated murine colitis. Astragalin is thus a potential therapeutic agent for IBD.
|
|
KEYWORD
|
|
Astragalin, Human colonic epithelial cells, NF-kappa B, Colitis, Inflammatory bowel disease
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|